Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP-Reference-Cited by-同舟云学术

Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP

Published:2017-08-10 Issue:8 Volume:12 Page:e0182829
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yu Jongwook,Oh Pyung Chun,Kim Minsu,Moon Jeonggeun,Park Yae Min,Lee Kyounghoon,Suh Soon Yong,Han Seung Hwan,Byun Kyunghee,Ahn Taehoon,Kang Woong Chol^ORCID

Funder

Dong-A Pharmaceutical Company, Republic of Korea

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129);J Daemen;EuroIntervention,2009

2. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis;T Palmerini;J Am Coll Cardiol,2013

3. Biomarkers in acute myocardial infarction;D Chan;BMC medicine,2010

4. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease;B Lindahl;N Engl J Med,2000

5. Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes;C Vieira;Rev Port Cardiol,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble ST2: A Novel Biomarker for Diagnosis and Prognosis of Cardiovascular Disease;Current Medical Science;2024-08

2. Long-term prognostic importance of high levels of sST2 in patient with AMI: a meta-analysis;American Journal of Translational Research;2024

3. Prediction of adverse outcomes within 12 months after myocardial infarction in patients over 70 years of age with frailty syndrome;Russian Journal of Cardiology;2023-12-19

4. Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure—A Prospective Observational Study;Journal of Clinical Medicine;2023-11-21

5. Chitosan‐sodium alginate‐polyethylene glycol‐Ally isothiocyante nanocomposites ameliorates isoproterenol‐induced myocardial infarction in rats;Journal of Biochemical and Molecular Toxicology;2023-09-19